Related Experiment Video

Updated: Apr 16, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Immunotherapy for lung cancer: for whom the bell tolls?

Pedro Madureira1, Ramon Andrade de Mello, Alessandro de Vasconcelos

  • 1Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|March 5, 2015
PubMed

Insights

Immunotherapy offers new hope for lung cancer patients by enhancing the immune response against tumors. This review explores promising immunotherapies like checkpoint inhibitors and vaccines for non-small cell lung cancer (NSCLC).

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Lung cancer remains a leading cause of cancer death globally.
  • Current personalized therapies offer limited improvement in prognosis for lung cancer patients.
  • Conventional chemotherapy can detrimentally impact the patient's immune system.

Purpose of the Study:

  • To review promising cancer immunotherapies for lung cancer treatment.
  • To highlight the advantages of novel immunotherapeutic agents.
  • To analyze current cancer treatment limitations from an immunological perspective.

Main Methods:

  • Review of recent clinical trials and scientific literature.
  • Focus on immunotherapeutic agents for metastatic non-small cell lung cancer (NSCLC).
  • Discussion of anti-tumor vaccines and dendritic cell-based therapies.

Main Results:

  • Immunotherapy aims to specifically boost anti-tumor immune responses.
  • Agents like ipilimumab, tremelimumab, nivolumab, and pembrolizumab show relevance in NSCLC.
  • Vaccines and dendritic cell therapies are potent immune response inducers.

Conclusions:

  • Immunotherapy represents a significant advancement in lung cancer treatment.
  • Understanding immunological mechanisms is crucial for improving cancer therapies.
  • Further research is needed to overcome challenges in current cancer treatment strategies.

More Related Videos

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.6K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

2.0K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K